FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Track all the latest updates and news of Saamya Biotech IPO.
June 17, 2024 9:49:00 PM
The biotechnology sector is one of the sectors which have contributed to enhancing the global profile of India in the last decade. At the beginning of the decade, this industry began to take shape ...
Published by : India InfolineJuly 19, 2024 12:26:00 PM
Artiva Biotherapeutics has upsized its IPO to $167 million as the allogeneic natural killer (NK) cell therapy prepares to list on the Nasdaq this morning. | The biotech has knocked its share price ...
Published by : FierceBiotechJuly 22, 2024 7:40:00 PM
Private biotech company acquisitions are on their fastest pace in years, a trend some in the industry say is driven by the abundance of mature, but not yet public, drug startups.
Published by : BioPharma DiveOctober 12, 2023 9:50:00 PM
After a decade of significant challenges, biotech's long-term sustainability depends on making fundamental changes to its traditional business model. A commonly held perception in the biotech ...
Published by : NatureJuly 16, 2024 3:30:00 AM
Initial public offerings in the biotech sector nosedived last year after ... There�s no indication yet on how much it is looking to raise with the IPO � its filing suggests $100 million ...
Published by : pharmaphorumFebruary 8, 2023 9:44:00 AM
There were only 36 biotech IPOs last year, compared with 68 in 2015 and a record 85 in 2014 � and a rebound was expected in 2017. Are biotech IPOs back in fashion? | pharmaphorum Skip to main ...
Published by : pharmaphorumOctober 4, 2023 11:33:00 PM
Ginkgo Bioworks' (NYSE:DNA) announcement of Zymergen's bankruptcy filing on Tuesday highlights how the biotech IPO boom in 2021 has unraveled amid rising interest rates and falling share prices.
Published by : Seeking Alpha on MSNJune 28, 2024 10:44:00 AM
The offering is expected to close on 1 July. Earlier this month, the US-based biotech said that it planned to use part of the IPO proceeds to advance its lead asset ESK-001 into multiple Phase III ...
Published by : Yahoo FinanceAugust 11, 2023 1:25:00 PM
Concord Biotech IPO GMP According to several websites that track activities in the unregulated market, the Concord Biotech IPO was commanding a grey market premium (GMP) in the range of Rs 145-149 ...
Published by : MSNAugust 11, 2023 3:31:00 AM
Concord Biotech is expected to announce its share allotment status today, August 11. The shares of Concord Biotech were subscribed almost 25 times. The shares are expected to be listed on the ...
Published by : Business Insider IndiaIPO Allotment Status is now available online for Saamya Biotech India Limited.
Saamya Biotech India Limited IPO was closed on September 28, 2007.
Saamya Biotech India Limited IPO listing info:
IPO Listing Date: Friday, October 19, 2007
BSE Script Code: 532905
Listing in: B1 Group
ISIN: INE320H01019
Issue Price: Rs 10/- Per Equity Share
Face Value : Rs 10/- Per Equity Share
Incorporated in 2002, Saamya Biotech India Limited (SBIL) is a Hyderabad based Biotech company. SBIL manufacture and market bio pharmaceutical and recombinant protein products to medical and other industries.
SBIL is entering the capital markets with an initial public offering, IPO of 1,50,00,000 Equity Shares through a Fixed Price Issue.
The price for the issue has been fixed at Rs 10/- for equity share of Rs 10/-. The issue opens on September 25, 2007, and closes for subscription on September 28, 2007. The equity shares of the company are proposed to be listed on the Bombay Stock Exchange (BSE).
The Saamya Biotech IPO is proposed to open on September 25, 2007. The IPO application ends on September 28, 2007.
Retail investors can apply in the retail or non-institutional investor category from September 25, 2007 to September 28, 2007. The Saamya Biotech IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Saamya Biotech IPO will open for subscription on September 25, 2007. The public issue will close on September 28, 2007.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|